# OnCo record nct07237100 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07237100/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07237100", "NCT07237100" ;
  schema:name "Mirdametinib in Patients With Advanced NF1-mutant Melanoma"@en ;
  schema:description "A phase 2 trial of Mirdametinib in Advanced melanoma, run by Kevin Kim, MD, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07237100/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07237100> ;
  onco:status "recruiting" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "2" ;
  onco:cancers <https://onco.cc/cancers/advanced-melanoma/> ;
  onco:drugs <https://onco.cc/drugs/mirdametinib/> .